Close
Almac
Achema middle east

WHO Demands More Study On People Living With Long COVID

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Specialized Laboratory Equipment Requirements for Biologics and Biosimilar Development

The development of complex biological molecules requires a specialized toolkit distinct from traditional small-molecule chemistry. This article details the critical laboratory equipment—from advanced bioreactors to high-resolution characterization tools—that enables the precise engineering and rigorous analysis required for successful biologics and biosimilar innovation.

Next-Generation Laboratory Equipment Redefining Drug Discovery Workflows

Advanced technologies such as AI-integrated high-throughput screening platforms and automated assay systems are fundamentally transforming early-stage pharmaceutical research. These innovations address critical bottlenecks in productivity and data quality, enabling research teams to accelerate timeline-to-candidate selection while enhancing the predictive accuracy of drug discovery campaigns.

Redefining Success Metrics in Pharma Portfolio Management

Shift from traditional R&D metrics focused on milestone completion and budget adherence to outcome-based, value-focused metrics that measure strategic impact, learning velocity, and long-term portfolio health while aligning organizational behavior with strategic objectives.
- Advertisement -

The WHO has urged nations to invest promptly in research, recovery, and rehabilitation in order to treat the post-COVID-19 syndrome seriously.

At least 17 million people in the 53 Member States of the WHO European Region may have encountered post-COVID-19 conditions, also known as long COVID, in the first two years of the pandemic, according to a new simulation done for WHO by the Institute for Health Metrics and Evaluation at the University of Washington School of Medicine in the US. Or, to put it another way, between 2020 and 2021, an estimated 17 million individuals matched the WHO definition of a new case of extended COVID with symptoms that lasted at least three months.

According to the model, the significant rise in verified COVID-19 instances from late 2020 through 2021 will be the main cause of the 307% surge of new long-term COVID cases found between 2020 and 2021.

Additionally, the modelling indicates that women are twice as likely as men to have a long COVID. Additionally, one in three females and one in five males are likely to develop protracted COVID in severe COVID-19 cases that require hospitalisation.

Dr. Hans Henri Kluge, WHO’s regional director for Europe, stated that while there is still much to learn about long-term COVID, particularly how it manifests in vaccinated versus unvaccinated communities and how it affects re-infections, these data highlight the urgent need for additional research, financing, assistance, and togetherness with those who suffer from this condition.

Millions of people in their region, which spans Central Asia and Europe, are still experiencing crippling symptoms months after contracting COVID-19. They can’t bear their suffering any longer. He added that governments and health stakeholders must work together to develop solutions that are supported by data and analysis.

The aggregate phrase post COVID-19 condition or long COVID refers to the collection of persistent symptoms that some patients endure after having COVID-19. While the majority of COVID-19 sufferers recover fully, it is suspected that 10–20% experience a range of short-, mid-, and long-term side effects, including fatigue, dyspnea, and cognitive impairment.

Long-term COVID can both directly and indirectly damage a person’s mental health as well as their capacity to carry out daily tasks like work or household chores.

Latest stories

Related stories

Specialized Laboratory Equipment Requirements for Biologics and Biosimilar Development

The development of complex biological molecules requires a specialized toolkit distinct from traditional small-molecule chemistry. This article details the critical laboratory equipment—from advanced bioreactors to high-resolution characterization tools—that enables the precise engineering and rigorous analysis required for successful biologics and biosimilar innovation.

Next-Generation Laboratory Equipment Redefining Drug Discovery Workflows

Advanced technologies such as AI-integrated high-throughput screening platforms and automated assay systems are fundamentally transforming early-stage pharmaceutical research. These innovations address critical bottlenecks in productivity and data quality, enabling research teams to accelerate timeline-to-candidate selection while enhancing the predictive accuracy of drug discovery campaigns.

Redefining Success Metrics in Pharma Portfolio Management

Shift from traditional R&D metrics focused on milestone completion and budget adherence to outcome-based, value-focused metrics that measure strategic impact, learning velocity, and long-term portfolio health while aligning organizational behavior with strategic objectives.

Smarter Resource Planning for Complex Pharma Development Portfolios

Align limited resources with complex pharmaceutical portfolios through capacity forecasting, skills-based planning, and dynamic resource reallocation, improving execution outcomes without increasing costs or overburdening teams.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »